References: Shukla
Last Updated: December 4, 2009	Print | Email

Andersen, M.E. & Krewski, D. (2009). Toxicity testing in the 21^st century: Bringing the vision to life. Toxicol. Sci. 107, 324-330.

Austin, C.P., Kavlock, R. & Tice, R.R. (2008). Tox21: Putting a Lens on the Vision of Toxicity Testing in the 21^st Century. http://alttox.org/ttrc/overarching-challenges/way-forward/austin-kavlock-tice/

Austin, C.P., Brady, L.S., Insel, T.R. & Collins, F.S. (2004). NIH Molecular Libraries Initiative. Science. 306, 1138-1139.

Beniashvili, D. (1994). Experimental Tumors in Monkeys, CRC Press.

Goldberg, A.M. & Frazier, J.M. (1989). Alternatives to animals in toxicity testing. Sci. Am. 261, 24-30.

Huang, R., Southall, N., Cho, M.H., Xia, M., Inglese, J. & Austin, C.P. (2008). Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. Chem. Res. Toxicol. 21, 659-667.

Huang, R., Southall, N., Xia, M., Cho, M.H., Jadhav, A., Nguyen, D.T., Inglese, J., Tice, R.R. & Austin, C.P. (2009). Weighted feature significance: A simple, interpretable model of compound toxicity based on the statistical enrichment of structural features. Toxicol. Sci. 112, 385-393.

Krewski, D., Andersen, M.E., Mantus, E. & Zeise, L. (2009). Toxicity testing in the 21^st century: Implications for human health risk assessment. Risk Anal. 29, 474-479.

National Research Council (NRC). (2007). Toxicity Testing in the 21^st Century: A Vision and a Strategy, National Academy Press, Washington, D.C.

National Toxicology Program. (2004). A National Toxicology Program for the 21^st Century: A Roadmap for the Future. http://ntp.niehs.nih.gov/files/NTPrdmp.pdf

Rangarajan, A. & Weinberg, R.A. (2003). Opinion: Comparative biology of mouse versus human cells: Modelling human cancer in mice. Nat. Rev. Cancer. 3, 952-959.

Rowan, A.N. (1983). Alternatives: Interaction between science and animal welfare. In: Product Safety Evaluation (ed. AM Goldberg), pp 113-133. Mary Ann Liebert, Inc., New York.

Schnecke, V. & Bostrom, J. (2006). Computational chemistry-driven decision making in lead generation. Drug Discov. Today. 11, 43-50.

Williams, G. & Weisburger, G. (1993). Chemical carcinogenesis. Toxicology, The Basic Science of Poisons, McGraw-Hill, New York.

Xia, M., Huang, R., Witt, K.L., Southall, N., Fostel, J., Cho, M.H., Jadhav, A., Smith, C.S., Inglese, J., Portier, C.J., Tice, R.R. & Austin, C.P. (2008). Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 116, 284-291.

Xia, M., Guo, V., Huang, R., Inglese, J., Nirenberg, M. & Austin, C.P. (2009a). A Cell-based beta-Lactamase Reporter Gene Assay for the CREB Signaling Pathway. Curr. Chem. Genomics. 3, 7-12.

Xia, M., Huang, R., Guo, V., Southall, N., Cho, M.H., Inglese, J., Austin, C.P. & Nirenberg, M. (2009b). Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memory. Proc. Natl. Acad. Sci. U.S.A. 106, 2412-2417.

Xia, M., Huang, R., Sun, Y., Semenza, G.L., Aldred, S.F., Witt, K.L., Inglese, J., Tice, R.R. & Austin, C.P. (2009c). Identification of chemical compounds that induce HIF-1alpha activity. Toxicol. Sci. 112, 153-163.

Zurlo, J., Rudacille, D. & Goldberg, A.M. (1993). Animals and Alternatives in Testing: History, Science, and Ethics, Mary Ann Liebert, Inc.